Scilex’s Semnur Pharmaceuticals to go public through $2.5B SPAC merger as it advances sciatica prospect FiercePharma
Source: Scilex’s Semnur Pharmaceuticals to go public through .5B SPAC merger as it advances sciatica prospect – FiercePharma
1 min to read